Breathe Well Live Well
|
Pharmaxis asthma treatment found safe, but is it effective?
Australian Life Scientist A phase IIa trial of Pharmaxis' (ASX:PXS) experimental allergic asthma drug, ASM8, has been shown safe, but more trials will be required to demonstrate efficacy. Asthma sufferers will have to wait a little longer before they have a potential new … |
View full post on asthma – Google News
|
Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge …
Sacramento Bee ARIDOL, the only dry powder bronchial challenge test approved for use in the United States, is used to assess bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. ARIDOL should not be used as … |
View full post on asthma – Google News
|
Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge …
PR Newswire (press release) ARIDOL, the only dry powder bronchial challenge test approved for use in the United States, is used to assess bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. ARIDOL should not be used as … |
View full post on asthma – Google News
|
Pharmaxis Receives J-Code For ARIDOL® (Mannitol Inhalation Powder) Bronchial …
MarketWatch (press release) ARIDOL should not be used as a stand alone test to assess asthma or as a screening test for asthma, but as part of a physician's overall assessment of asthma. The new J-code becomes effective on January 1, 2012. J-codes are used by providers to bill … |
View full post on asthma – Google News
|
Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the …
PR Newswire (press release) It is used for the assessment of bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. … |
View full post on asthma – Google News
|
FDA Approves Pharmaxis' ARIDOL™ (Mannitol Inhalation Powder) Bronchial …
Kansas City Star ARIDOL is used for the assessment of bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. … |
View full post on asthma – Google News
 TopNews Arab Emirates |
US approval for Pharmaxis asthma test
Sydney Morning Herald PHARMAXIS, which develops treatments for respiratory and autoimmune diseases, has won regulatory approval to sell its asthma test kit, Aridol, in the US. … US approval proves a shot in the arm Pharmaxis gets the right news at the right time US Food and Drug Administration Approves Aridol |
View full post on asthma – Google News
TopNews Arab Emirates |
FDA Approves Pharmaxis' Asthma Test Kit Aridol
TopNews United Kingdom Pharmaxis' asthma test kit Aridol has been shown green signal by the US Food and Drug Administration for commercialization in US. … US approves Pharmaxis asthma test Pharmaxis (PXS) $2.40: Tim Boreham Pharmaxis gets the right news at the right time |
View full post on asthma – Google News
|
US approves Pharmaxis asthma test
Sydney Morning Herald Pharmaxis Ltd, which develops treatments for respiratory and autoimmune diseases, has won regulatory approval to sell its asthma test kit, Aridol, … Pharmaxis (PXS) $2.40: Tim Boreham |
View full post on asthma – Google News